Meticulous Research®—a leading global
market research company, published a research report titled, ‘Remote Patient Monitoring
Market by Product ([Blood Glucose, Respiratory, Blood Pressure, Fetal, Weight
Monitoring] [Wearable, Portable, Benchtop]) Application (Diabetes, Oncology,
Cardiovascular, Neurological Disorders) End User - Global Forecast to 2031.’
According to this latest publication from
Meticulous Research®, the global remote patient monitoring market is projected to
reach $116.84 billion by 2031, at a CAGR of 13.7%.
The factors driving the market are the increasing geriatric population, rising
prevalence of chronic diseases, shortage of healthcare professionals, growing
awareness regarding the benefits of RPM, such as convenience and improved patient
outcomes, rising need to reduce healthcare costs, and favorable government
initiatives promoting remote patient monitoring. Additionally, technological
advancements in telehealth & remote patient monitoring, emerging economies
with growing patient populations, increasing adoption of wearable devices,
advancements in sensor technologies, and integration of artificial intelligence
with RPM serve are expected to create market growth opportunities.
However, data accuracy & reliability
concerns and barriers limiting the use of remote patient monitoring
technologies, such as limited access and low technology literacy among
patients, restrain the growth of the market. Additionally, data security &
privacy concerns and increased overhead expenses due to the need for additional
staff to manage the RPM system are some of the challenges impacting the
market’s growth.
Download Free PDF Sample Copy of the Report
(with COVID-19 Impact Analysis): https://www.meticulousresearch.com/download-sample-report/cp_id=5343
Key Players:
The key players profiled in the remote patient
monitoring market report are Medtronic plc (Ireland), Koninklijke Philips N.V.
(Netherlands), OMRON Corporation (Japan), Boston Scientific Corporation (U.S.),
Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), GE HealthCare
Technologies, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Baxter
International, Inc. (U.S.), Oracle Corporation (U.S.), DexCom, Inc. (U.S.), and
VitalConnect, Inc. (U.S.).
The global remote patient monitoring market is
segmented by Product (Monitoring Devices {By Functionality [Blood Glucose
Monitoring, Cardiac Monitoring, Neurological Monitoring, Respiratory
Monitoring, Multiparameter Monitoring, Blood Pressure Monitoring, Fetal and
Neonatal Monitoring, Weight Monitoring, and Other Monitoring Devices] By Type
[Wearables, Portable, and Benchtop Monitoring Devices]}, Software, Services),
Application (Diabetes, Cardiovascular Diseases, Neurological Disorders,
Respiratory Diseases, Oncology, Other Applications), End User (Home-care
Settings, Hospitals, Long-term Care Facilities, Other End Users), and
Geography. The study also evaluates industry competitors and analyzes the
market at the regional and country levels.
To gain more insights into the market with a
detailed table of content and figures, click here:
https://www.meticulousresearch.com/product/remote-patient-monitoring-market-5343
Based on the product, in 2024, the
monitoring devices segment is expected to account for the largest share of the
market. The large share of the segment is attributed to factors such as the
rising elderly population, advancements in sensor technologies, integration of
artificial intelligence (AI) in monitoring devices, and the rising demand for
personalized healthcare.
Based on application, in 2024, the diabetes
segment is expected to account for the largest share of the market. The large
share of this segment is due to factors such as the utilization of telehealth,
the increasing prevalence of diabetes, and the rising need to monitor diabetes
patients.
Based on end user, in 2024, the home-care
settings segment is expected to account for the largest share of the market.
The large market share of this segment is attributed to the growing shift
towards home-care settings, the rising prevalence of chronic diseases among the
elderly population, the shortage of healthcare professionals, and increasing
consumer awareness regarding the monitoring of chronic conditions through RPM
tools.
Request Sample Report:
https://www.meticulousresearch.com/request-sample-report/cp_id=5343
Geographic Review:
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S.,
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America,
and the Middle East & Africa. In 2024, North America is expected to account
for the largest share of the remote patient monitoring market, followed by
Europe. North America’s significant market share can be attributed to factors
such as the high adoption of technologically advanced products and devices, the
presence of key market players, the well-established healthcare system, high
consumer awareness, and high disposable incomes.
You can Buy Report from Here: https://www.meticulousresearch.com/Checkout/99206508
Key questions answered in the
report-
· Which are
the high-growth market segments in terms of product, application, end user, and
region/country?
· What was
the historical market for remote patient monitoring across the globe?
· What are
the market forecasts and estimates for the period 2024–2031?
· What are
the major drivers, restraints, challenges, opportunities, and trends in the
global market of remote patient monitoring market?
· Who are the
major players in the global remote patient monitoring market?
· What is the
competitive landscape like, and who are the market leaders in the global remote
patient monitoring market?
· What are
the recent developments in the remote patient monitoring market?
· What are
the different strategies adopted by the major players in the remote patient
monitoring market?
· What are
the geographical trends and high growth regions/countries?
Comments
0 comment